Shanghai Universal BiotechLtd Balance Sheet Health
Financial Health criteria checks 6/6
Shanghai Universal BiotechLtd has a total shareholder equity of CN¥2.1B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.3B and CN¥216.4M respectively.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.39b |
| Equity | CN¥2.08b |
| Total liabilities | CN¥216.40m |
| Total assets | CN¥2.30b |
Recent financial health updates
No updates
Recent updates
We Think That There Are More Issues For Shanghai Universal BiotechLtd (SZSE:301166) Than Just Sluggish Earnings
Nov 05
Pinning Down Shanghai Universal Biotech Co.,Ltd.'s (SZSE:301166) P/S Is Difficult Right Now
Oct 15What Shanghai Universal Biotech Co.,Ltd.'s (SZSE:301166) 25% Share Price Gain Is Not Telling You
May 08Shanghai Universal BiotechLtd's (SZSE:301166) Sluggish Earnings Might Be Just The Beginning Of Its Problems
May 03Financial Position Analysis
Short Term Liabilities: 301166's short term assets (CN¥1.9B) exceed its short term liabilities (CN¥189.3M).
Long Term Liabilities: 301166's short term assets (CN¥1.9B) exceed its long term liabilities (CN¥27.1M).
Debt to Equity History and Analysis
Debt Level: 301166 is debt free.
Reducing Debt: 301166 has no debt compared to 5 years ago when its debt to equity ratio was 13%.
Debt Coverage: 301166 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 301166 has no debt, therefore coverage of interest payments is not a concern.